PRODUCT LITERATURE

Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature

---

In March 2020, the World Health Organization declared the spread of SARS-CoV-2 a global pandemic. To date, coronavirus disease-2019 (COVID-19) has spread to over 200 countries, leading to over 1.6 million cases and over 99,000 deaths. Given that there is neither a vaccine nor proven treatment for COVID-19, there is currently an urgent need for effective pharmacotherapy. To address the need for an effective treatment of SARS-CoV-2 during the worldwide pandemic, this systematic review of intravenous (IV) remdesivir was performed. Remdesivir, an anti-viral prodrug originally developed to treat Ebola
virus disease, has shown broad spectrum activity against the Coronavirus family.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Jubi-R

Specific Detail Info

-

Statement of Responsibility

West J Emerg Med. 2020;21(4)737–741

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment